Cargando…

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity

Despite the success of conjugate vaccination against meningococcal group C (MenC) disease, post-vaccination, some individuals still exhibit rapid waning of initially protective bactericidal antibody levels. The mechanism of this relative loss of humoral protection remains undetermined. In this repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wing, James B., Smart, Lynne, Borrow, Ray, Findlow, Jamie, Findlow, Helen, Lees, Andrew, Read, Robert C., Heath, Andrew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275607/ https://www.ncbi.nlm.nih.gov/pubmed/22347446 http://dx.doi.org/10.1371/journal.pone.0031160

Ejemplares similares

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Findlow, Jamie, et al.
Publicado: (2019)

Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine
por: Findlow, Jamie, et al.
Publicado: (2014)

Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
por: Elias, Johannes, et al.
Publicado: (2013)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
por: Vesikari, Timo, et al.
Publicado: (2020)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

27. Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm
por: Findlow, Jamie, et al.
Publicado: (2021)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
por: Ladhani, Shamez N., et al.
Publicado: (2012)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Ladhani, Shamez N., et al.
Publicado: (2016)

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination
por: Holme, Daniel, et al.
Publicado: (2015)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Tin Tin Htar, Myint, et al.
Publicado: (2020)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
por: Presa, Jessica, et al.
Publicado: (2019)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

The Distribution and ‘In Vivo’ Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis
por: Lucidarme, Jay, et al.
Publicado: (2013)

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017
por: Nuttens, Charles, et al.
Publicado: (2022)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
por: Liberator, Paul, et al.
Publicado: (2020)

Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review
por: Pardo de Santayana, Carmen, et al.
Publicado: (2023)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Parikh, Sydel R., et al.
Publicado: (2016)

An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015
por: Lucidarme, Jay, et al.
Publicado: (2016)

Herd Protection against Meningococcal Disease through Vaccination
por: Clark, Stephen A., et al.
Publicado: (2020)

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage
por: Lucidarme, Jay, et al.
Publicado: (2015)

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
por: Tall, Haoua, et al.
Publicado: (2015)

Meningococcal conjugate vaccines: optimizing global impact
por: Terranella, Andrew, et al.
Publicado: (2011)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants
por: Findlow, H., et al.
Publicado: (2019)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
Publicado: (2015)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
por: Pace, David, et al.
Publicado: (2015)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

A comparison of national vaccination policies to prevent serogroup B meningococcal disease
por: Sulis, Giorgia, et al.
Publicado: (2022)

Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens
por: Clark, Stephen A., et al.
Publicado: (2014)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Factors contributing to the immunogenicity of meningococcal conjugate vaccines
por: Bröker, Michael, et al.
Publicado: (2016)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
por: Nunes, Amélia Maria Pithon Borges, et al.
Publicado: (2016)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
por: McNeil, Lisa K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r47mics47jth101oc09mcbiv1g